Ledger.Open graph →

SEC Form D · filed August 8, 2017

Kitov Pharmaceuticals Holdings Ltd

Offering

$2.0M

Sold

$2.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

TEL AVIV, L3

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Richard F. Lunsford · conshohocken, PADirector Stephen F. Waltrich · conshohocken, PAExec · Director Stavros Koutsantonis · Exeter, NHExec Mark Mcgarry · BOSTON, MADirector Jay Bush · BOSTON, MADirector Carl S. Pappo · New York, NYExec · Director Travis York · BOSTON, MADirector Kyle York · BOSTON, MAExec · Director Aiden S. Redmond · New York, NYExec · Director Paul Young · Exeter, NHDirector Avraham Ben-Tzvi · Tel Aviv, L3Exec James S. Robertson · Houston, TXExec · Director Jeffrey Grimberg · Seattle, WADirector Steven J. Grover · Missoula, MTExec · Director Wendy W. Dicicco · Pittsburgh, PAExec · Director Quinn Rotchford · Seattle, WADirector John K. Mastrototaro · Dania Beach, FLDirector Steven K. Seger · Dania Beach, FLExec · Director Gary Pinkerton · Wall Township, NJDirector Scott Baker · Overland, KSDirector Scott Duba · Overland, KSExec Avraham Ben-Tzvi · Omer, L3Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗